Mustang Bio, Inc. (MBIO) DCF Valuation

Mustang Bio, Inc. (MBIO) DCF Valoración

US | Healthcare | Biotechnology | NASDAQ
Mustang Bio, Inc. (MBIO) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Mustang Bio, Inc. (MBIO) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¿Buscas evaluar el valor intrínseco de Mustang Bio, Inc.? Nuestra calculadora MBIO DCF integra datos del mundo real con amplias opciones de personalización, lo que le permite ajustar los pronósticos y mejorar sus opciones de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -43.3 -54.3 -64.0 -71.1 -48.1 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 1.4 1.8 2.3 3.0 2.2 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -44.6 -56.1 -66.4 -74.2 -50.3 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 61.4 97.8 109.6 75.7 6.2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .1 .3 3.9
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.9 3.5 3.5 6.8 6.3 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -3.7 -4.4 -5.4 -3.1 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -46.3 -58.1 -64.1 -75.5 -50.3 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -46.8 -59.1 -67.2 -72.4 -52.3 -2.4 .0 .0 .0 .0
WACC, % 37.45 37.45 36.34 37.45 37.45 37.23 37.23 37.23 37.23 37.23
PV UFCF
SUM PV UFCF -1.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -4
Equity Value 2
Diluted Shares Outstanding, MM 9
Equity Value Per Share 0.23

What You Will Receive

  • Pre-Filled Financial Model: Mustang Bio, Inc.'s (MBIO) actual data facilitates accurate DCF valuation.
  • Complete Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
  • Real-Time Calculations: Automatic updates ensure immediate visibility of results as adjustments are made.
  • Investor-Ready Template: A polished Excel file crafted for professional-level valuation.
  • Customizable and Reusable: Designed for adaptability, allowing for repeated use in comprehensive forecasts.

Key Features

  • 🔍 Real-Life MBIO Financials: Pre-filled historical and projected data for Mustang Bio, Inc. (MBIO).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Mustang Bio’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Mustang Bio’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Mustang Bio, Inc. (MBIO) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see recalculated results, including Mustang Bio, Inc. (MBIO)'s intrinsic value.
  • Step 5: Make informed investment decisions or create reports based on the outputs.

Why Choose Mustang Bio, Inc. (MBIO)?

  • Innovative Solutions: Cutting-edge therapies developed to address unmet medical needs.
  • Proven Expertise: A team of experienced professionals dedicated to advancing biotechnology.
  • Robust Pipeline: Diverse portfolio of candidates in various stages of development.
  • Commitment to Quality: Adherence to the highest standards in research and manufacturing processes.
  • Positive Impact: Focused on improving patient outcomes and transforming lives.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for analyzing Mustang Bio, Inc. (MBIO) investments.
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in Mustang Bio, Inc. (MBIO).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech companies like Mustang Bio, Inc. (MBIO) are valued in the marketplace.

What the Template Contains

  • Historical Data: Includes Mustang Bio, Inc.'s (MBIO) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Mustang Bio, Inc.'s (MBIO) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Mustang Bio, Inc.'s (MBIO) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.